https://www.selleckchem.com/pr....oducts/vorapaxar.htm
Whether HIV infection is associated with differences in clinical outcomes among people hospitalized with COVID-19 is uncertain. To evaluate the impact of HIV infection on COVID-19 outcomes among hospitalized patients. Using the American Heart Association's COVID-19 Cardiovascular Disease registry, we used hierarchical mixed effects models to assess the association of HIV with in-hospital mortality accounting for patient demographics and comorbidities and clustering by hospital. Secondary outcomes included major adverse cardiac events
Like
Comment
Share
